134 related articles for article (PubMed ID: 11712722)
1. A phase II study of methylphenidate for depression in advanced cancer.
Homsi J; Nelson KA; Sarhill N; Rybicki L; LeGrand SB; Davis MP; Walsh D
Am J Hosp Palliat Care; 2001; 18(6):403-7. PubMed ID: 11712722
[TBL] [Abstract][Full Text] [Related]
2. Factors associated with response to methylphenidate in advanced cancer patients.
Yennurajalingam S; Palmer JL; Chacko R; Bruera E
Oncologist; 2011; 16(2):246-53. PubMed ID: 21282671
[TBL] [Abstract][Full Text] [Related]
3. Methylphenidate side effects in advanced cancer: a retrospective analysis.
Lasheen W; Walsh D; Mahmoud F; Davis MP; Rivera N; Khoshknabi DS
Am J Hosp Palliat Care; 2010 Feb; 27(1):16-23. PubMed ID: 19745210
[TBL] [Abstract][Full Text] [Related]
4. Methylphenidate for fatigue in advanced cancer: a prospective open-label pilot study.
Sarhill N; Walsh D; Nelson KA; Homsi J; LeGrand S; Davis MP
Am J Hosp Palliat Care; 2001; 18(3):187-92. PubMed ID: 11406895
[TBL] [Abstract][Full Text] [Related]
5. Methylphenidate for depression in hospice practice: a case series.
Homsi J; Walsh D; Nelson KA; LeGrand S; Davis M
Am J Hosp Palliat Care; 2000; 17(6):393-8. PubMed ID: 11886041
[TBL] [Abstract][Full Text] [Related]
6. Effects of methylphenidate on fatigue and depression: a randomized, double-blind, placebo-controlled trial.
Kerr CW; Drake J; Milch RA; Brazeau DA; Skretny JA; Brazeau GA; Donnelly JP
J Pain Symptom Manage; 2012 Jan; 43(1):68-77. PubMed ID: 22208450
[TBL] [Abstract][Full Text] [Related]
7. Multicentre, double-blind, randomised placebo-controlled clinical trial on the efficacy of methylphenidate on depressive symptoms in advanced cancer patients.
Centeno C; Sanz A; Cuervo MA; Ramos D; Hernansanz S; Gonzalez J; Almaraz MJ; Lama M; Vara F; Nabal M; Pascual A
BMJ Support Palliat Care; 2012 Dec; 2(4):328-33. PubMed ID: 24654216
[TBL] [Abstract][Full Text] [Related]
8. Methylphenidate and/or a nursing telephone intervention for fatigue in patients with advanced cancer: a randomized, placebo-controlled, phase II trial.
Bruera E; Yennurajalingam S; Palmer JL; Perez-Cruz PE; Frisbee-Hume S; Allo JA; Williams JL; Cohen MZ
J Clin Oncol; 2013 Jul; 31(19):2421-7. PubMed ID: 23690414
[TBL] [Abstract][Full Text] [Related]
9. Patient-controlled methylphenidate for the management of fatigue in patients with advanced cancer: a preliminary report.
Bruera E; Driver L; Barnes EA; Willey J; Shen L; Palmer JL; Escalante C
J Clin Oncol; 2003 Dec; 21(23):4439-43. PubMed ID: 14645434
[TBL] [Abstract][Full Text] [Related]
10. Treatment of depression with methylphenidate in patients difficult to wean from mechanical ventilation in the intensive care unit.
Rothenhäusler HB; Ehrentraut S; von Degenfeld G; Weis M; Tichy M; Kilger E; Stoll C; Schelling G; Kapfhammer HP
J Clin Psychiatry; 2000 Oct; 61(10):750-5. PubMed ID: 11078036
[TBL] [Abstract][Full Text] [Related]
11. Comparing effects of methylphenidate, sertraline and placebo on neuropsychiatric sequelae in patients with traumatic brain injury.
Lee H; Kim SW; Kim JM; Shin IS; Yang SJ; Yoon JS
Hum Psychopharmacol; 2005 Mar; 20(2):97-104. PubMed ID: 15641125
[TBL] [Abstract][Full Text] [Related]
12. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity.
Research Units on Pediatric Psychopharmacology Autism Network
Arch Gen Psychiatry; 2005 Nov; 62(11):1266-74. PubMed ID: 16275814
[TBL] [Abstract][Full Text] [Related]
13. Use of methylphenidate for the management of fatigue in Chinese patients with cancer.
Siu SW; Law M; Liu RK; Wong KH; Soong IS; Kwok AO; Ng KH; Lam PT; Leung TW
Am J Hosp Palliat Care; 2014 May; 31(3):281-6. PubMed ID: 23650644
[TBL] [Abstract][Full Text] [Related]
14. Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial.
Bruera E; Valero V; Driver L; Shen L; Willey J; Zhang T; Palmer JL
J Clin Oncol; 2006 May; 24(13):2073-8. PubMed ID: 16648508
[TBL] [Abstract][Full Text] [Related]
15. Methylphenidate hydrochloride improves cognitive function in patients with advanced cancer and hypoactive delirium: a prospective clinical study.
Gagnon B; Low G; Schreier G
J Psychiatry Neurosci; 2005 Mar; 30(2):100-7. PubMed ID: 15798785
[TBL] [Abstract][Full Text] [Related]
16. A phase II study of methylphenidate for the treatment of fatigue.
Hanna A; Sledge G; Mayer ML; Hanna N; Einhorn L; Monahan P; Daggy J; Bhatia S
Support Care Cancer; 2006 Mar; 14(3):210-5. PubMed ID: 16096772
[TBL] [Abstract][Full Text] [Related]
17. Pilot study to determine the optimal dose of methylphenidate for an n-of-1 trial for fatigue in patients with cancer.
Hardy JR; Carmont SA; O'Shea A; Vora R; Schluter P; Nikles CJ; Mitchell GK
J Palliat Med; 2010 Oct; 13(10):1193-7. PubMed ID: 20831434
[TBL] [Abstract][Full Text] [Related]
18. Use of methylphenidate in patients with cancer.
Sood A; Barton DL; Loprinzi CL
Am J Hosp Palliat Care; 2006; 23(1):35-40. PubMed ID: 16450661
[TBL] [Abstract][Full Text] [Related]
19. Methylphenidate: established and expanding roles in symptom management.
Prommer E
Am J Hosp Palliat Care; 2012 Sep; 29(6):483-90. PubMed ID: 22144657
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Methylphenidate on Fatigue in Advanced Cancer: An Aggregated N-of-1 Trial.
Mitchell GK; Hardy JR; Nikles CJ; Carmont SA; Senior HE; Schluter PJ; Good P; Currow DC
J Pain Symptom Manage; 2015 Sep; 50(3):289-96. PubMed ID: 25896104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
